Doklady Biochemistry and Biophysics

, Volume 471, Issue 1, pp 387–389 | Cite as

Neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors

  • T. A. Gudasheva
  • V. V. Grigoriev
  • K. N. Koliasnikova
  • V. L. Zamoyski
  • S. B. Seredenin
Biochemistry, Biophysics, and Molecular Biology


We have previously shown that neuropeptide cycloprolylglycine (CPG) increases the content of brain-derived neurotrophic factor (BDNF) in the culture of neuronal cells under normal conditions and in pathology. This is the first study to show that CPG at a physiological concentration of 10–6 M significantly enhances the transmembrane AMPA currents in rat cerebellar Purkinje cells. Thus, CPG is a positive endogenous modulator of AMPA receptors. It was assumed that the neuropsychotropic effects of CPG are implemented as a result of BDNF accumulation after the activation of AMPA receptors by this neuropeptide.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gudasheva, T.A., Vasilevich, N.I., Zolotov, N.N., Lezina, V.P., Rozenberg, S.G., Kravchenko, E.V., Ostrovskaya, R.U., Voronina, T.A., Rozantsev, G.G., and Skoldinov, A.P., Khim.-Farm. Zh., 1991, vol. 25, no. 6, pp. 12–16.Google Scholar
  2. 2.
    Gudasheva, T.A., Boiko, S.S., Akparov, V.Kh., Ostrovskaya, R.U., Rozantsev, G.G., Voronina, T.A., Zherdev, V.P., and Seredenin, S.B., Dokl. Akad. Nauk, 1996, vol. 350, no. 6, pp. 834–836.PubMedGoogle Scholar
  3. 3.
    Gudasheva, T.A., Boyko, S.S., Akparov, V.Kh., Ostrovskaya, R.U., Skoldinov, A.P., Rozantsev, G.G., Voronina, T.A., Zherdev, V.P., and Seredenin, S.B., FEBS Lett., 1996, vol. 391, pp. 149–152.CrossRefPubMedGoogle Scholar
  4. 4.
    Gudasheva, T.A., Ostrovskaya, R.U., Trofimov, S.S., Voronina, T.A., Skoldinov, A.P., and Seredenin, S.B., Byull. Eksp. Biol. Med., 1999, vol. 116, no. 10, pp. 411–413.Google Scholar
  5. 5.
    Povarnina, P.Yu., Kolyasnikova, K.N., Nikolaev, S.V., Antipova, T.A., and Gudasheva, T.A., Byull. Eksp. Biol. Med., 2015, vol. 160, no. 11, pp. 600–603.Google Scholar
  6. 6.
    Kolyasnikova, K.N., Gudasheva, T.A., Nazarova, G.A., Antipov, P.I., Nikolaev, S.V., Antipova, T.A., Voronina, T.A., and Seredenin, S.B., Eksp. Klin. Farmakol., 2012, vol. 75, no. 9, pp. 3–6.Google Scholar
  7. 7.
    Gudasheva, T.A., Konstantinopol’skii, M.A., Ostrovskaya, R.U., and Seredenin, S.B., Byull. Eksp. Biol. Med., 2001, vol. 131, no. 5, pp. 547–550.CrossRefGoogle Scholar
  8. 8.
    Copani, A., Genazzani, A.A., Aleppo, G., Casabona, G., Canonico, P.L., Scapagnini, U., and Nicoletti, F., J. Neurochem., 1992, vol. 58, no. 4, pp. 1199–1204.CrossRefPubMedGoogle Scholar
  9. 9.
    Partin, K.M., Fleck, M.W., and Mayer, M.L., J. Neurosci., 1996, vol. 16, no. 21, pp. 6634–6647.PubMedGoogle Scholar
  10. 10.
    Jin, R., Clark, S., Weeks, A.M., Dudman, J.T., Gouaux, E., and Partin, K.M., J. Neurosci., 2005, vol. 25, no. 39, pp. 9027–9036.CrossRefPubMedGoogle Scholar
  11. 11.
    Lauterborn, J.C., Lynch, G., Vanderklish, P., Arai, A., and Gall, C.M., J. Neurosci., 2000, vol. 20, no. 1, pp. 8–21.PubMedGoogle Scholar
  12. 12.
    Jourdi, H., Hsu, Y.-T., Zhou, M., Qin, Q., Bi, X., and Baudry, M., J. Neurosci., 2009, vol. 29, no. 27, pp. 8688–8697.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Gudasheva, T.A., Koliasnikova, K.N., Antipova, T.A., and Seredenin, S.B., Dokl. Biochem. Biophys., 2016, vol. 469, pp. 273–276.CrossRefPubMedGoogle Scholar
  14. 14.
    Autry, A.E. and Monteggia, L.M., Pharmacol. Rev., 2012, vol. 64, pp. 238–258.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Ferro, J.N., de Aquino, F.L., de Brito, R.G., Santos, P.L., Quintans, J., de Souza, L.C., de Araujo, A.F., Diaz, B.L., Lucca-Junior, W., Quintans-Junior, L.J., and Barreto, E., Clin. Exp. Pharmacol. Physiol, 2015, vol. 42, no. 12, pp. 1287–1295.CrossRefPubMedGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2016

Authors and Affiliations

  • T. A. Gudasheva
    • 1
  • V. V. Grigoriev
    • 2
  • K. N. Koliasnikova
    • 1
  • V. L. Zamoyski
    • 2
  • S. B. Seredenin
    • 1
  1. 1.Zakusov Research Institute of PharmacologyRussian Academy of Medical SciencesMoscowRussia
  2. 2.Institute of Physiologically Active CompoundsRussian Academy of SciencesChernogolovka, Moscow oblastRussia

Personalised recommendations